SEC61G and cancer: Subgroup analyses further demonstrated that SEC61G expression correlated with OS in different HNSCC anatomic sites, including the larynx (P = 0.010, Figure 4C), tonsil (P = 0.005, Figure 4D) and floor of mouth (P = 0.032, Figure 4E) cancers.